Zimmer Biomet shares could rise 25 pct – Barron’s

(Reporting by David Henry in New York; Editing by Alan Crosby)

March 27 (Reuters) – Shares of hip, knee and shoulder replacement maker Zimmer Biomet Holdings could rise 25 percent as the market sees signs that the company is recovering from merger indigestion, according to an article in the latest edition of Barron’s.


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button